Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, March 20, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Emily Bodnar Reiterated (VTYX) at Strong Buy and Held Target at $50 on, Mar 20th, 2023
Emily Bodnar of HC Wainwright & Co., Reiterated "Ventyx Biosciences, Inc." (VTYX) at Strong Buy and Held Target at $50 on, Mar 20th, 2023.
Emily has made no other calls on VTYX in the last 4 months.
There are 3 other peers that have a rating on VTYX. Out of the 3 peers that are also analyzing VTYX, 0 agree with Emily's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Emily
- Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $54 on, Tuesday, January 31st, 2023
- Jeff Jones of "Oppenheimer" Maintained at Buy with Increased Target to $60 on, Friday, January 27th, 2023
- Chris Shibutani of "Goldman Sachs" Initiated at Strong Buy and Held Target at $50 on, Monday, December 19th, 2022
